Literature DB >> 20919931

Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice.

Heather B Eccleston1, Kelly K Andringa, Angela M Betancourt, Adrienne L King, Sudheer K Mantena, Telisha M Swain, Heather N Tinsley, Ryan N Nolte, Tim R Nagy, Gary A Abrams, Shannon M Bailey.   

Abstract

Obesity-related pathologies, such as nonalcoholic fatty liver disease, are linked to mitochondrial dysfunction and nitric oxide (NO) deficiency. Herein, we tested the hypothesis that a high-fat diet (HFD) modifies the liver mitochondrial proteome and alters proteins involved in NO metabolism, namely arginase 1 and endothelial NO synthase. Male C57BL/6 mice were fed a control or HFD and liver mitochondria were isolated for proteomics and reactive oxygen species measurements. Steatosis and hepatocyte ballooning were present in livers of HFD mice, with no pathology observed in the controls. HFD mice had increased serum glucose and decreased adiponectin. Mitochondrial reactive oxygen species was increased after 8 weeks in the HFD mice, but decreased at 16 weeks compared with the control, which was accompanied by increased uncoupling protein 2. Using proteomics, 22 proteins were altered as a consequence of the HFD. This cohort consists of oxidative phosphorylation, lipid metabolism, sulfur amino acid metabolism, and chaperone proteins. We observed a HFD-dependent increase in arginase 1 and decrease in activated endothelial NO synthase. Serum and liver nitrate + nitrite were decreased by HFD. In summary, these data demonstrate that a HFD causes steatosis, alters NO metabolism, and modifies the liver mitochondrial proteome; thus, NO may play an important role in the processes responsible for nonalcoholic fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20919931      PMCID: PMC3118652          DOI: 10.1089/ars.2010.3395

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  53 in total

Review 1.  Role of L-arginine in nitric oxide production in health and hypertension.

Authors:  Niwanthi W Rajapakse; David L Mattson
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-11-28       Impact factor: 2.557

Review 2.  Mechanisms of disease progression in nonalcoholic fatty liver disease.

Authors:  Janice Jou; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

Review 3.  Autophagy and ethanol-induced liver injury.

Authors:  Terrence M Donohue
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 4.  MAM: more than just a housekeeper.

Authors:  Teruo Hayashi; Rosario Rizzuto; Gyorgy Hajnoczky; Tsung-Ping Su
Journal:  Trends Cell Biol       Date:  2009-01-12       Impact factor: 20.808

5.  Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).

Authors:  G L Tipoe; C T Ho; E C Liong; T M Leung; T Y H Lau; M L Fung; A A Nanji
Journal:  Histol Histopathol       Date:  2009-09       Impact factor: 2.303

6.  An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice.

Authors:  Sanjoy Roychowdhury; Megan R McMullen; Michele T Pritchard; Amy G Hise; Nico van Rooijen; M Edward Medof; Abram B Stavitsky; Laura E Nagy
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 7.  eNOS, metabolic syndrome and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Trends Endocrinol Metab       Date:  2009-07-31       Impact factor: 12.015

8.  Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.

Authors:  Kaori Minehira; Stephen G Young; Claudio J Villanueva; Laxman Yetukuri; Matej Oresic; Mark K Hellerstein; Robert V Farese; Jay D Horton; Frederic Preitner; Bernard Thorens; Luc Tappy
Journal:  J Lipid Res       Date:  2008-06-01       Impact factor: 5.922

Review 9.  How mitochondria produce reactive oxygen species.

Authors:  Michael P Murphy
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

10.  Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.

Authors:  Marijana Radonjic; Jorn R de Haan; Marjan J van Erk; Ko Willems van Dijk; Sjoerd A A van den Berg; Philip J de Groot; Michael Müller; Ben van Ommen
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more
  37 in total

Review 1.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Inducible nitric oxide synthase-derived nitric oxide reduces vagal satiety signalling in obese mice.

Authors:  Yang Yu; Sung Jin Park; Michael J Beyak
Journal:  J Physiol       Date:  2018-12-18       Impact factor: 5.182

3.  Metabolic signatures suggest o-phosphocholine to UDP-N-acetylglucosamine ratio as a potential biomarker for high-glucose and/or palmitate exposure in pancreatic β-cells.

Authors:  Saleem Yousf; Devika M Sardesai; Abraham B Mathew; Rashi Khandelwal; Jhankar D Acharya; Shilpy Sharma; Jeetender Chugh
Journal:  Metabolomics       Date:  2019-03-29       Impact factor: 4.290

4.  A Combined N-terminomics and Shotgun Proteomics Approach to Investigate the Responses of Human Cells to Rapamycin and Zinc at the Mitochondrial Level.

Authors:  Joanna Bons; Charlotte Macron; Catherine Aude-Garcia; Sebastian Alvaro Vaca-Jacome; Magali Rompais; Sarah Cianférani; Christine Carapito; Thierry Rabilloud
Journal:  Mol Cell Proteomics       Date:  2019-03-15       Impact factor: 5.911

5.  Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice.

Authors:  Angela M Betancourt; Adrienne L King; Jessica L Fetterman; Telisha Millender-Swain; Rachel D Finley; Claudia R Oliva; David R Crowe; Scott W Ballinger; Shannon M Bailey
Journal:  Biochem J       Date:  2014-07-15       Impact factor: 3.857

6.  Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis.

Authors:  Suvarthi Das; Ratanesh Kumar Seth; Ashutosh Kumar; Maria B Kadiiska; Gregory Michelotti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-24       Impact factor: 4.052

Review 7.  Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease.

Authors:  Ariel E Feldstein; Shannon M Bailey
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

Review 8.  Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics.

Authors:  Tanecia Mitchell; Balu Chacko; Scott W Ballinger; Shannon M Bailey; Jianhua Zhang; Victor Darley-Usmar
Journal:  Biochem Soc Trans       Date:  2013-02-01       Impact factor: 5.407

9.  Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease.

Authors:  Chad A Galloway; Hakjoo Lee; Paul S Brookes; Yisang Yoon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-31       Impact factor: 4.052

10.  Hepatic proteomic analysis revealed altered metabolic pathways in insulin resistant Akt1(+/-)/Akt2(-/-) mice.

Authors:  Brian A Pedersen; Weiwen Wang; Jared F Taylor; Omar S Khattab; Yu-Han Chen; Robert A Edwards; Puya G Yazdi; Ping H Wang
Journal:  Metabolism       Date:  2015-09-12       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.